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Pure akinesia with gait freezing (PAGF) is considered a clinical phenotype of progressive
supranuclear palsy. The brain atrophy and cognitive deficits in PAGF are expected to be
less prominent than in classical Richardson’s syndrome (RS), but this hypothesis has not
been explored yet. We reviewed the medical records of 28 patients with probable RS, 19
with PAGF, and 29 healthy controls, and compared cortical thickness, subcortical gray
matter volume, and neuropsychological performance among the three groups. Patients
with PAGF had thinner cortices in frontal, inferior parietal, and temporal areas compared
with controls; however, areas of cortical thinning in PAGF patients were less extensive
than those in RS patients. In PAGF patients, hippocampal, and thalamic volumes were
also smaller than controls, whereas subcortical gray matter volumes in PAGF and RS
patients were comparable. In a comparison of neuropsychological tests, PAGF patients
had better cognitive performance in executive function, visual memory, and visuospatial
function than RS patients had. These results demonstrate that cognitive impairment,
cortical thinning, and subcortical gray matter atrophy in PAGF patients resemble to those
in RS patients, though the severity of cortical thinning and cognitive dysfunction is milder.
Our results suggest that, PAGF and RS may share same pathology but that it appears
to affect a smaller proportion of the cortex in PAGF.
Keywords: pure akinesia with gait freezing, freezing of gait, progressive supranuclear palsy, cortical thickness,
subcortical volume, cognition
Introduction
Pure akinesia was first described by Imai et al. in 1974, and their cases were characterized by
freezing or blocking during gait, speaking, and writing (Imai andNarabayashi, 1974;Williams et al.,
2007). However, patients did not respond to levodopa, nor did they display other characteristics
of parkinsonism including limb rigidity, resting tremor, cognitive impairment, or abnormal eye
movement. Since this initial description, many similar cases have been reported using various
terms including pure akinesia (Imai et al., 1987; Matsuo et al., 1991; Riley et al., 1994), primary
progressive freezing of gait (Achiron et al., 1993; Factor et al., 2006), and gait ignition failure
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(Atchison et al., 1993). Although there are exceptions (Quinn
et al., 1989; Imai and Narabayashi, 1990; Molinuevo et al.,
2003), most pathological studies consistently suggest that pure
akinesia is associated with progressive supranuclear palsy (PSP)-
tau pathology (Matsuo et al., 1991; Imai et al., 1993; Mizusawa
et al., 1993; Riley et al., 1994; Yoshikawa et al., 1997; Compta et al.,
2007; Williams et al., 2007). Williams et al. proposed diagnostic
criteria for pure akinesia with gait freezing (PAGF) and selected
seven patients fulfilling the criteria from the Queen Square Brain
Bank (Williams et al., 2007). Among them, PSP-tau pathology
was found in six cases and Lewy body pathology in the other.
Therefore, the authors suggested that PAGF should be considered
the third phenotype of PSP.
Although, the severity of brain atrophy and cognitive deficit
in patients with PAGF is expected to be less prominent
than that in patients with classical Richardson’s syndrome
(RS) by definition, the patterns of brain atrophy or cognitive
characteristics of PAGF have not been explored yet. In this study,
we compared cortical thickness, subcortical gray matter volume,
and cognitive performance between PAGF and RS to investigate
the topographic pattern of brain atrophy and cognitive deficits in
patients with PAGF.
Materials and Methods
Participants
The present study was retrospective and enrolled 28 patients with
probable RS and 19 from the movement disorders clinic at a
tertiary referral center (Yonsei University Severance Hospital)
between January 2008 and December 2014. Probable RS was
diagnosed according to the NINDS-SPSP clinical criteria (Litvan
et al., 1996), and the PAGF were identified using the following
criteria proposed by Williams et al.: history of gait or speech
freezing of gradual onset, absence of limb rigidity and tremor, no
sustained response to levodopa, no dementia or ophthalmoplegia
in the first 5 years of disease, and exclusion of vascular disease
or Binswanger’s disease by magnetic resonance imaging (MRI)
(Williams et al., 2007). Parkinsonian motor symptoms were
assessed using the Unified PD Rating Scale (UPDRS) part III. All
patients were treated with more than 750 mg/day of levodopa,
and a patient was regarded as unresponsive to levodopa when
the UPDRS part III score reduced less than 30% or increased
following at least 6 months of levodopa treatment (Williams
et al., 2005). Additionally, 29 healthy age- and sex-matched
controls were selected who had completed brain MRI scans
and neuropsychological assessment for medical screening. All
healthy controls’ brains appeared normal on MRI finding, and
they displayed normal cognitive performance.
The study protocol was approved by the institutional review
board (IRB) on human experimentation, and exempted from
providing informed consent by the IRB due to the retrospective
design.
MRI Acquisition
A Philips 3.0 T scanner (Philips Achieva; Philips Medical
System, Best, the Netherlands) with a SENSE head-8 coil was
used to obtain high-resolution T1-weighted magnetic resonance
(MR) volume datasets. Imaging was performed using a three-
dimensional T1-TFE sequence configured with the following
parameters: axial acquisition with a 224× 224 matrix; 256× 256
reconstructed matrix; 220× 220-mm field of view; 0.86× 0.86×
1.0-mm voxels; echo time, 4.6ms; repetition time, 9.6ms; flip
angle, 8◦; and slice gap, 0mm.
Image Processing
Cortical Thickness
Images were processed using the standardMontreal Neurological
Institute (MNI) anatomical pipeline. The native MR images
were normalized into a standardized stereotaxic space using
affine transformation and intensity non-uniformity artifacts in
normalized images were corrected using the N3 algorithm
(Collins et al., 1994; Sled et al., 1998). After correction using
the brain extraction tool (BET), the skull area was removed
from images; then, the remaining areas were classified as
white matter (WM), gray matter (GM), cerebrospinal fluid
(CSF), or background using an advanced neural net classifier
(Smith, 2002). The surfaces of the inner and outer cortex,
consisting of 40,962 vertices, were extracted automatically using
the Constrained Laplacian-based Automated Segmentation with
Proximities (CLASP) algorithm (MacDonald et al., 2000; Kim
et al., 2005). Cortical thickness was defined using the t-link
method, which captures the Euclidean distance between the
linked vertices (MacDonald et al., 2000; Im et al., 2006).
Each individual thickness map was transformed to a surface
group template using a two-dimensional (2D) surface-based
registration after diffusion smoothing with 20-mm full-width
half-maximum to increase the signal-to-noise ratio and improve
the ability of detection of population changes (Robbins et al.,
2004). To assess group differences in cortical thickness, a general
linear model was constructed with age, sex, and intracranial
volume (ICV) as independent variables and each of the vertices
of thickness as a dependent variable. For multiple comparisons,
the results were thresholded at a false-discovery-rate corrected
p-value of 0.05 and cluster of 100 (Genovese et al., 2002).
Subcortical Gray Matter Volume
Subcortical structures were automatically segmented in the
native space of each MRI using the automated anatomical
labeling (AAL) template (Tzourio-Mazoyer et al., 2002). AAL
regions were deformed onto a standardized stereotaxic space
by inverse spatial normalization. Individual tissue classification
maps for GM were used to mask segmentation of native AAL
regions. We then computed the volumes of four subcortical
regions (hippocampus, caudate, putamen, and thalamus) from
the masked individual AAL regions. To compare the volume of
subcortical structures between groups, we also applied general
linear model with sex, age, and ICV.
Neuropsychological Assessment
The neuropsychological performance of 20 patients with RS
and 12 with PAGF was evaluated within 2 months from MRI
acquisition, using the following cognitive subsets: forward and
backward digit span, the Korean version of the Boston Naming
Test (K-BNT), Rey Complex Figure Test (RCFT) copying, 20-
min delayed recall using the Seoul Verbal Learning Test and the
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RCFT, semantic and phonemic fluency using the Controlled Oral
Word Association Test (COWAT), and color-word reading of the
Stroop test. Mental state was assessed using the Korean version
of Mini-Mental State Examination (K-MMSE) and the Clinical
Dementia Rating scale (CDR).
Statistical Analysis
For baseline characteristics, categorical variables were
compared using the chi-square test, and continuous variables
by independent t-test and One-Way analysis of variance
(ANOVA). Because of the relatively small sample size and
skewed distribution of the neuropsychological data, the
Kruskal−Wallis test was used to compare neuropsychological
performance among groups. For post hoc analyses, Bonferroni’s
method was conducted for ANOVA, and Dunn’s test followed by
Bonferroni’s correction was conducted for the Kruskal−Wallis
test. Statistical analyses were performed using SPSS Statistics 20
(IBM SPSS, Armonk, NY, USA), and a p < 0.05 was considered
to indicate statistical significance.
Results
Demographic Characteristics
The demographic characteristics and clinical symptoms of
the subjects are shown in Table 1. There were no significant
differences among RS and PAGF patients, and controls in term
of age at MRI scan or gender. RS and PAGF patients were
comparable in age at disease onset and time from onset to MRI
scan. However, compared with RS patients, the PAGF patients
had longer disease duration (8.3 ± 2.5 vs. 4.2 ± 1.9 years, p <
0.001) at the time of medical records review and milder motor
symptoms (UPDRS motor score; 20.9 ± 9.6 vs. 36.4 ± 16.7,
p = 0.001) at the first hospital visit. The patients with PAGF
had speech disturbance (17.9 vs. 46.4%, p = 0.036) and nuchal
rigidity (42.1 vs. 89.3%, p = 0.001) less frequently than those
with RS did, while the frequency of gait disturbance and finger
bradykinesia was comparable between the groups of PAGF and
RS. No patients with PAGF showed ophthalmoplegia, tremor, or
limb rigidity.
Cortical Thickness
The results of cortical thickness analyses are shown in Figure 1.
PAGF patients had significant cortical thinning in bilateral
inferior frontal, left orbitofrontal, right anterior cingulate,
bilateral insula, bilateral supramarginal, right angular and
precunial, and bilateral temporal areas, extending into the
parahippocampal and lingual gyri (Figure 1B, Electronic
Supplementary Table 1). Areas where the cortex was thinner in
RS patients compared with controls were extensive, involving
bilateral frontal, bilateral anterior and middle cingulate,
bilateral insula, bilateral pericentral, bilateral parietal (bilateral
supramarginal and left angular and inferior parietal areas), and
bilateral temporal areas, extending into parahippocampal and
occipital areas (Figure 1A, Electronic Supplementary Table 2).
Cortical thickness did not significantly differ between patients
with PAGF and those with RS. When compared at a liberal
threshold (uncorrected p < 0.001), the cortex of RS was thinner
TABLE 1 | Demographic characteristics and clinical symptoms of patients
with Richardson’s syndrome and pure akinesia with gait freezing.
RS PAGF NC P-value
Age at MRI, year 67.6 ± 6.5 72.0 ± 6.1 68.4 ± 5.7 0.051
Male/female 14/14 11/8 13/16 0.676
Age at disease onset, year 64.5 ± 7.2 68.1 ± 6.1 N/A 0.082
Disease duration, year 4.2 ± 1.9 8.5 ± 2.7 N/A < 0.001
Time from onset to MRI, year 3.1 ± 1.8 3.9 ± 2.7 N/A 0.244
Clinical symptom at MRI
UPDRS motor score 36.4 ± 16.7 20.9 ± 9.6 N/A 0.001
Gait disturbance, n (%) 26 (92.9) 19 (100) N/A 0.508
Speech disturbance, n (%) 13 (46.4) 15 (17.9) N/A 0.036
Ophthalmoplegia, n (%) 28 (100) 0 (0) N/A < 0.001
Tremor, n (%) 6 (21.4) 0 (0) N/A 0.068
Finger bradykinesia, n (%) 12 (42.9) 3 (15.8) N/A 0.063
Limb rigidity, n (%) 22 (78.6) 0 (0) N/A < 0.001
Nuchal rigidity, n (%) 25 (89.3) 8 (42.1) N/A 0.001
Data are expressed as mean ± SD or n (%).
RS, Richardson’s syndrome; PAGF, pure akinesia with gait freezing; NC, normal control;
MRI, magnetic resonance imaging; UPDRS, Unified Parkinson’s disease rating scale; N/A,
not applicable.
in the anterior cingulate gyrus compared with the PAGF patients
(Figure 1C, Electronic Supplementary Table 3). No areas where
PAGF patients exhibited more cortical thinning than RS patients
were observed.
Subcortical Gray Matter Volume
Compared with controls, PAGF patients had smaller volume in
left hippocampus (post hoc p = 0.005) and left thalamus (post
hoc p = 0.018), whereas there was no volume loss in caudate
nucleus and putamen (Table 2). Similarly, RS patients also had
smaller volume in left hippocampus (post hoc p = 0.014) and
bilateral thalami (post hoc p = 0.015 for right, 0.024 for left) than
did controls. There was no volume difference between PAGF and
RS patients.
Neuropsychological Findings
The neuropsychological performance of the RS, PAGF, and
control groups is presented in Table 3. The duration of education
was comparable among the three groups. K-MMSE scores of
RS and PAGF patients were significantly lower than those of
controls, but there was no difference between the two patient
groups.
RS patients showed poorer performance on all tested
neuropsychological subsets compared with controls, including
attention (forward and backward digit span), confrontational
naming (K-BNT), visuospatial function (RCFT copy), verbal and
visual memory (delayed recall of SVLT and RCFT), verbal fluency
(both semantic and phonemic tasks), and color-word Stroop test.
PAGF patients had significantly poorer scores in confrontational
naming, the visuospatial task, verbal memory, and semantic
fluency compared with controls. When cognitive scores of PAGF
and RS patients were compared, PAGF patients scored higher
on the visuospatial task, visuospatial memory, both semantic and
phonemic fluencies, and the color-word Stroop test.
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FIGURE 1 | Cortical thickness analyses in patients with Richardson’s syndrome (RS), pure akinesia with gait freezing (PAGF), and controls.
Comparisons of (A) RS patients with controls, (B) PAGF patients with controls, and (C) RS patients to PAGF patients.
Discussion
This is the first study investigating cognitive performance
and brain atrophic pattern in PAGF. PAGF patients had
cortical thinning in frontal, inferior parietal, and temporal
areas compared with controls; however, the areas of cortical
thinning in patients with PAGF were less extensive than in RS
patients. Additionally, PAGF patients had smaller volume in the
hippocampus and thalamus than controls had, whereas their
subcortical gray matter volumes were comparable to those in
RS patients. In a comparison of neuropsychological tests, PAGF
patients had better cognitive performance in frontal executive
function, visual memory, and visuospatial function than did RS
patients. These data suggest that PAGF may involve a similar
pathological burden in subcortical gray matter as in RS but that
this pathology may occur in a more limited cortical area than in
RS, which may underlie the difference in cognitive performance.
Previous pathological studies indicate that the distribution
and severity of pathological changes in PAGF are milder than
in RS. Specifically, PAGF involves less severe tau pathology
in the motor cortex, striatum, pontine nuclei, and cerebellum
than in RS (Williams et al., 2007; Ahmed et al., 2008). These
results suggest that the difference in pathological burden between
the two diseases may explain the relatively milder clinical
symptoms of PAGF. Moreover, a functional neuroimaging study
using positron emission tomography also revealed that although
cerebral metabolism is similar, PAGF patients displayed an
attenuated pattern of brain glucosemetabolismwith preservation
of frontal metabolism compared with RS patients (Park et al.,
2009). In the present study, cortical thickness analysis indicated
that PAGF has cortical thinning in inferior and medial frontal,
inferior parietal, and temporal areas, whereas superior frontal,
superior parietal, and occipital areas are preserved. Interestingly,
the same areas are thinned in RS patients, but in our RS
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TABLE 2 | Volumetric analyses for subcortical gray matter in patients with Richardson’s syndrome and pure akinesia with gait freezing.
RS PAGF NC P-value Post hoc P-value
RS vs. NC PAGF vs. NC RS vs. PAGF
Hippocampus 8251 ± 699 8222 ± 607 8635 ± 780 0.020 ns 0.038 ns
Right 4102 ± 383 4100 ± 386 4241 ± 401 ns
Left 4148 ± 380 4122 ± 298 4394 ± 408 0.002 0.014 0.005 ns
Caudate nucleus 7759 ± 1382 7965 ± 1185 7750 ± 936 ns
Right 4118 ± 826 4252 ± 650 4007 ± 436 ns
Left 3641 ± 607 3712 ± 575 3743 ± 522 ns
Putamen 6620 ± 1455 6373 ± 1459 6319 ± 1663 ns
Right 3556 ± 777 3374 ± 712 3365 ± 865 ns
Left 3063 ± 711 3000 ± 764 2954 ± 854 ns
Thalamus 7277 ± 1205 7488 ± 1385 8038 ± 1499 0.006 0.012 0.028 ns
Right 3617 ± 681 3792 ± 771 4021 ± 790 0.011 0.015 ns ns
Left 3660 ± 567 3697 ± 690 4017 ± 769 0.007 0.024 0.018 ns
Data are expressed as mean ± SD.
RS, Richardson’s syndrome; PAGF, pure akinesia with gait freezing; NC, normal control; ns, not significant.
TABLE 3 | Neuropsychological performance of patients with Richardson’s syndrome and pure akinesia with gait freezing.
RS (n = 20) PAGF (n = 12) NC (n = 29) P-value Post hoc P-value
median IQR median IQR median IQR RS vs. NC PAGF vs. NC RS vs. PAGF
Years of education, year 9 7.5-12 13.5 11.5−16 14 8−16 0.196
K-MMSE score 23.5 17−26.5 26 25−27.5 29 28−29 <0.0001 <0.0001 0.002 ns
CDR 0.75 0.5−1 0.5 0.25−0.5 0 0−0.5 <0.0001 <0.0001 0.03 ns
Neuropsychological tests
Forward digit span 5.5 4−6 6 5−6.5 6 6−7 0.004 0.005 ns ns
Backward digit span 2 0−3 3.5 2.5−4 4 4−4 <0.0001 <0.0001 ns ns
K-BNT 39.5 26.5−43.5 42 38−49 50 46−53 <0.0001 <0.0001 0.03 ns
RCFT copy 18.5 9−26.5 33.5 30−34 36 35−36 <0.0001 <0.0001 0.04 0.02
SVLT delayed recall 2.5 0.5−4 3.5 2−4.5 7 6−8 <0.0001 <0.0001 0.0006 ns
RCFT delayed recall 6 2−10 15.5 10.5−19 18.5 15.5−24 <0.0001 <0.0001 ns 0.009
Semantic fluency 11 8−17 27 21−31.5 39 33−44 <0.0001 <0.0001 0.03 0.02
Phonemic fluency 5 3−10.5 19.5 13.5−29.5 26 21−30 <0.0001 <0.0001 ns 0.002
Color-word Stroop 20 5.5−30.5 63.5 48.5−80.5 89.5 78.5−109 <0.0001 <0.0001 ns 0.005
RS, Richardson’s syndrome; PAGF, pure akinesia with gait freezing; NC, normal control; IQR, interquartile range; K-MMSE, Korean version of Mini-mental state examination; CDR, clinical
dementia rating; K-BNT, Korean version of Boston Naming Test; RCFT, Rey complex figure test; SVLT, Seoul verbal learning test; ns, not significant.
The analysis was performed using the analysis of covariance with age and years of education as covariates. Post hoc analyses were conducted using Dunn’s methods with Bonferroni’s
correction.
patients, cortical thinning affected a more extensive proportion
of the brain, including inferior and medial frontal, parietal, and
temporal areas, consistent with previous MR-based volumetric
neuroimaging studies (Brenneis et al., 2004; Cordato et al., 2005).
Direct comparison indicates that PAGF involves greater cortical
thinning in the anterior cingulate gyrus than that seen in RS.
Therefore, the present results are in line with pathological studies
in supporting the conclusion that PAGF shares pathological
characteristics with RS, but to a less severe extent.
Subcortical gray matter volume analysis revealed that PAGF
patients have significant volume loss in left hippocampus and left
thalamus compared with controls; the distribution of volume loss
in subcortical gray matter was quite similar to that in RS. Further
direct comparison showed that subcortical volume loss in these
areas was comparable between PAGF and RS patients. Previous
imaging studies have found diverse patterns of subcortical gray
matter volume loss in RS; several investigators reported general
atrophy in wide subcortical areas including the hippocampus,
caudate nuclei, globus pallidus, putamen, and thalamus, while
others did not detect any significant volume loss in these areas
(Schulz et al., 1999; Cordato et al., 2000, 2002, 2005; Hanyu et al.,
2001; Brenneis et al., 2004; Paviour et al., 2006; Messina et al.,
2011). To our knowledge, ours in the first direct comparison of
subcortical structures between PAGF and RS, finding that the
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severity and distribution of subcortical gray matter pathology are
similar. However, a further study with a larger sample and more
broadly accepted methodology is needed to resolve whether the
subcortical pathological burden differs between PAGF and RS.
Cognitive impairment is well-known to be common in RS;
about two-thirds of RS patients exhibit below-normal cognitive
performance (Rittman et al., 2013). The most common deficit
in RS is frontal executive dysfunction, which appears early
in disease progression (Pillon et al., 1986; Soliveri et al.,
2000; Lange et al., 2003; Bak et al., 2005; Rittman et al.,
2013). Moreover, phonemic and semantic verbal fluency are
severely impaired in RS, a key differentiator from Parkinson’s
disease or corticobasal degeneration (Pillon et al., 1991; Rittman
et al., 2013). Additionally, about one-third of PSP patients
also exhibit dysfunction in other cognitive domains, such as
memory and visuospatial function (Pillon et al., 1986; Soliveri
et al., 2000; Lange et al., 2003; Bak et al., 2005). However,
no characteristic pattern of cognitive impairment has been
determined in PAGF. In the present study, relative to controls,
RS patients showed poorer cognitive performance in attention,
naming, the color-word Stroop test, semantic and phonemic
verbal fluencies, memory, and visuospatial tasks, in accordance
with previous neuropsychological results. Cognitive dysfunction
in PAGF appeared less extensive than in RS; PAGF patients had
lower scores in semantic fluency, naming, verbal memory, and
visuospatial function tasks than controls. Directly comparing
the cognitive performance of PAGF with that of RS patients
revealed better scores in executive function, visual memory,
and visuospatial function tasks in PAGF patients. To speculate
on the neural correlates of cognitive dysfunction in patients
with PAGF, lower semantic fluency may result from cortical
thinning in frontal areas, impairment of verbal memory may
be related to hippocampal atrophy or cortical thinning in the
parahippocampal gyrus, and visuospatial dysfunction could be
associated with posterior cortical thinning. On the other hand,
better cognitive performance in PAGF compared with RS patients
may result from the difference in the extent of areas with
cortical thinning rather a difference in subcortical volume loss,
as subcortical gray matter volume loss was comparable. These
findings additionally support the conclusion that the cortical
pathological burden is reduced in PAGF compared with RS
patients, as this would lead to better cognitive performance.
This study has several limitations. First, the clinical
diagnoses of study subjects were not confirmed by pathological
examination. Especially in PAGF, this leaves open the possibility
that the sample included patients with a related disease, such as
PD-like pathology (Williams et al., 2007). Second, although this
study enrolled the largest number of PAGF patients until now,
it is still a relatively small sample. Further studies with larger
samples are required to confirm the present results. Finally,
the uncorrected threshold used in direct comparison between
cortical thickness of PAGF and RS patients may not fully protect
against results due to chance, increasing the likelihood of false
positives. Therefore, the significant clusters found in the present
study require further validation.
In conclusion, this study demonstrates that cognitive
impairment, cortical thinning, and subcortical gray matter
atrophy in PAGF resemble to RS, but that the severity of cortical
thinning and cognitive dysfunction is milder in PAGF. These
results suggest that PAGF and RS may share pathology, but its
extent and distribution may be less in PAGF than in RS.
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